The treatment of HIV associated thrombocytopenia in haemophiliacs

Clin Lab Haematol. 1990;12(3):237-45. doi: 10.1111/j.1365-2257.1990.tb00033.x.

Abstract

HIV associated thrombocytopenia occurs in 5-10% of asymptomatic individuals, and 25-45% of people with AIDS. A variety of treatments are available but the inherited bleeding disorder in addition to the thrombocytopenia makes management in haemophiliacs a special problem. The management of this double coagulopathy is described in seven patients. IV gammaglobulin and steroids were useful only in the short term; zidovudine produced a good response, could be taken orally, had anti-HIV activity and was well tolerated in asymptomatic HIV positive patients. Interferon was an alternative when zidovudine was ineffective or produced intolerable side-effects. Splenectomy was considered only after failure of other treatments because of the increased risks of bleeding.

MeSH terms

  • Acquired Immunodeficiency Syndrome / complications
  • Acquired Immunodeficiency Syndrome / drug therapy
  • Adolescent
  • Adult
  • Child
  • HIV Infections / complications*
  • Hemophilia A / complications*
  • Humans
  • Immunoglobulin G / therapeutic use
  • Infusions, Intravenous
  • Interferons / therapeutic use
  • Prednisolone / therapeutic use
  • Retrospective Studies
  • Splenectomy
  • Thrombocytopenia / etiology
  • Thrombocytopenia / therapy*
  • Zidovudine / therapeutic use

Substances

  • Immunoglobulin G
  • Zidovudine
  • Interferons
  • Prednisolone